Part identity
NDC00369-0056-01
Ferrous Fumarate Tablets
Key Pharmaceuticals Pty Ltd
Avg quote: 14 minFulfilled from Anaheim, CAAS9120:2025 · ISO 9001 · FAA AC 00-56BC of C, lot & date code with every line
Part description
Ferrous Fumarate Tablets
ASAP supports this specific part for replacement, spare-pool replenishment, retrofit, and urgent maintenance requirements. Quote requests can include alternate MPN, condition preferences, certification needs, and plant-specific receiving instructions so procurement gets a clear sourcing response before purchase.
Specifications
Certifications & documentation
- UL Recognized
- CE
- C of C available on request
KP
Manufacturer
Key Pharmaceuticals Pty Ltd
Authorized-distributor or qualified-aftermarket source. Parts shipped from this manufacturer include full traceability paperwork and counterfeit-mitigation per SAE AS6081.
View manufacturer profile →Characteristics Data of NSN 6505-00-761-5065, 6505007615065
| MRC | Criteria | Characteristic |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |
